Global Vunakizumab Supply, Demand and Key Producers, 2026-2032
The global Vunakizumab market size is expected to reach $ 185 million by 2032, rising at a market growth of 8.6% CAGR during the forecast period (2026-2032).
Vunakizumab is a humanized anti?IL?17A monoclonal antibody independently developed by Hengrui Medicine. It can specifically bind to Interleukin?17A (IL?17A), block its interaction with receptors, inhibit inflammatory signaling pathways, and reduce inflammation in the skin, joints and other tissues. It is mainly used for the treatment of psoriasis, ankylosing spondylitis, psoriatic arthritis and other autoimmune diseases, characterized by high affinity, long half?life, long dosing interval and good safety.In 2025, global vunakizumab production reached approximately 1.2 million vials.
Vunakizumab is a Class 1 domestic innovative drug independently developed by Hengrui Medicine and one of the first anti-IL-17A monoclonal antibodies approved in China. Since its launch, it has rapidly become an important participant in the therapeutic market for autoimmune diseases. With the advantages of high affinity, low immunogenicity, rapid onset and convenient administration, the drug has broken the long-term monopoly of imported IL-17A inhibitors and provided a domestic alternative for patients with psoriasis, ankylosing spondylitis and other diseases. Driven by three core factors, namely medical insurance coverage, expanded indications and optimized pricing, its market penetration has been continuously improved, making it a core growth product in the field of domestic autoimmunity. In terms of competitive landscape, vunakizumab and selicilizumab from Chuangxiang Jintai constitute the first echelon of domestic IL-17A inhibitors, forming a competition pattern of 'import-dominated, domestic catching-up' with imported products from Novartis, Eli Lilly and other companies. In the future, relying on Hengrui's commercialization capacity, medical insurance volume expansion effect and potential indication expansion (such as psoriatic arthritis and rheumatoid arthritis), vunakizumab is expected to further expand its market share and promote domestic substitution and price penetration in the domestic autoimmune disease treatment market.
This report studies the global Vunakizumab production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Vunakizumab and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Vunakizumab that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Vunakizumab total production and demand, 2021-2032, (Units)
Global Vunakizumab total production value, 2021-2032, (USD Million)
Global Vunakizumab production by region & country, production, value, CAGR, 2021-2032, (USD Million) & (Units), (based on production site)
Global Vunakizumab consumption by region & country, CAGR, 2021-2032 & (Units)
U.S. VS China: Vunakizumab domestic production, consumption, key domestic manufacturers and share
Global Vunakizumab production by manufacturer, production, price, value and market share 2021-2026, (USD Million) & (Units)
Global Vunakizumab production by Type, production, value, CAGR, 2021-2032, (USD Million) & (Units)
Global Vunakizumab production by Application, production, value, CAGR, 2021-2032, (USD Million) & (Units)
This report profiles key players in the global Vunakizumab market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Suzhou Shengdiya Biopharmaceutical, Jiangsu Hengrui Medicine, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Vunakizumab market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Vunakizumab Market, By Region:
1. How big is the global Vunakizumab market?
2. What is the demand of the global Vunakizumab market?
3. What is the year over year growth of the global Vunakizumab market?
4. What is the production and production value of the global Vunakizumab market?
5. Who are the key producers in the global Vunakizumab market?
6. What are the growth factors driving the market demand?
Vunakizumab is a humanized anti?IL?17A monoclonal antibody independently developed by Hengrui Medicine. It can specifically bind to Interleukin?17A (IL?17A), block its interaction with receptors, inhibit inflammatory signaling pathways, and reduce inflammation in the skin, joints and other tissues. It is mainly used for the treatment of psoriasis, ankylosing spondylitis, psoriatic arthritis and other autoimmune diseases, characterized by high affinity, long half?life, long dosing interval and good safety.In 2025, global vunakizumab production reached approximately 1.2 million vials.
Vunakizumab is a Class 1 domestic innovative drug independently developed by Hengrui Medicine and one of the first anti-IL-17A monoclonal antibodies approved in China. Since its launch, it has rapidly become an important participant in the therapeutic market for autoimmune diseases. With the advantages of high affinity, low immunogenicity, rapid onset and convenient administration, the drug has broken the long-term monopoly of imported IL-17A inhibitors and provided a domestic alternative for patients with psoriasis, ankylosing spondylitis and other diseases. Driven by three core factors, namely medical insurance coverage, expanded indications and optimized pricing, its market penetration has been continuously improved, making it a core growth product in the field of domestic autoimmunity. In terms of competitive landscape, vunakizumab and selicilizumab from Chuangxiang Jintai constitute the first echelon of domestic IL-17A inhibitors, forming a competition pattern of 'import-dominated, domestic catching-up' with imported products from Novartis, Eli Lilly and other companies. In the future, relying on Hengrui's commercialization capacity, medical insurance volume expansion effect and potential indication expansion (such as psoriatic arthritis and rheumatoid arthritis), vunakizumab is expected to further expand its market share and promote domestic substitution and price penetration in the domestic autoimmune disease treatment market.
This report studies the global Vunakizumab production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Vunakizumab and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Vunakizumab that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Vunakizumab total production and demand, 2021-2032, (Units)
Global Vunakizumab total production value, 2021-2032, (USD Million)
Global Vunakizumab production by region & country, production, value, CAGR, 2021-2032, (USD Million) & (Units), (based on production site)
Global Vunakizumab consumption by region & country, CAGR, 2021-2032 & (Units)
U.S. VS China: Vunakizumab domestic production, consumption, key domestic manufacturers and share
Global Vunakizumab production by manufacturer, production, price, value and market share 2021-2026, (USD Million) & (Units)
Global Vunakizumab production by Type, production, value, CAGR, 2021-2032, (USD Million) & (Units)
Global Vunakizumab production by Application, production, value, CAGR, 2021-2032, (USD Million) & (Units)
This report profiles key players in the global Vunakizumab market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Suzhou Shengdiya Biopharmaceutical, Jiangsu Hengrui Medicine, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Vunakizumab market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Vunakizumab Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- 120 mg / 1 ml
- 240 mg / 2 ml
- Innovator
- Generic
- Monoclonal Antibody
- Polyclonal Antibody
- Hospital
- Retail
- Online
- Moderate to Severe Plaque Psoriasis
- Ankylosing Spondylitis
- Others
- Suzhou Shengdiya Biopharmaceutical
- Jiangsu Hengrui Medicine
1. How big is the global Vunakizumab market?
2. What is the demand of the global Vunakizumab market?
3. What is the year over year growth of the global Vunakizumab market?
4. What is the production and production value of the global Vunakizumab market?
5. Who are the key producers in the global Vunakizumab market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 Vunakizumab Introduction
1.2 World Vunakizumab Supply & Forecast
1.2.1 World Vunakizumab Production Value (2021 & 2025 & 2032)
1.2.2 World Vunakizumab Production (2021-2032)
1.2.3 World Vunakizumab Pricing Trends (2021-2032)
1.3 World Vunakizumab Production by Region (Based on Production Site)
1.3.1 World Vunakizumab Production Value by Region (2021-2032)
1.3.2 World Vunakizumab Production by Region (2021-2032)
1.3.3 World Vunakizumab Average Price by Region (2021-2032)
1.3.4 North America Vunakizumab Production (2021-2032)
1.3.5 Europe Vunakizumab Production (2021-2032)
1.3.6 China Vunakizumab Production (2021-2032)
1.3.7 Japan Vunakizumab Production (2021-2032)
1.3.8 India Vunakizumab Production (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 Vunakizumab Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Vunakizumab Major Market Trends
2 DEMAND SUMMARY
2.1 World Vunakizumab Demand (2021-2032)
2.2 World Vunakizumab Consumption by Region
2.2.1 World Vunakizumab Consumption by Region (2021-2026)
2.2.2 World Vunakizumab Consumption Forecast by Region (2027-2032)
2.3 United States Vunakizumab Consumption (2021-2032)
2.4 China Vunakizumab Consumption (2021-2032)
2.5 Europe Vunakizumab Consumption (2021-2032)
2.6 Japan Vunakizumab Consumption (2021-2032)
2.7 South Korea Vunakizumab Consumption (2021-2032)
2.8 ASEAN Vunakizumab Consumption (2021-2032)
2.9 India Vunakizumab Consumption (2021-2032)
3 WORLD MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Vunakizumab Production Value by Manufacturer (2021-2026)
3.2 World Vunakizumab Production by Manufacturer (2021-2026)
3.3 World Vunakizumab Average Price by Manufacturer (2021-2026)
3.4 Vunakizumab Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Vunakizumab Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Vunakizumab in 2025
3.5.3 Global Concentration Ratios (CR8) for Vunakizumab in 2025
3.6 Vunakizumab Market: Overall Company Footprint Analysis
3.6.1 Vunakizumab Market: Region Footprint
3.6.2 Vunakizumab Market: Company Product Type Footprint
3.6.3 Vunakizumab Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Vunakizumab Production Value Comparison
4.1.1 United States VS China: Vunakizumab Production Value Comparison (2021 & 2025 & 2032)
4.1.2 United States VS China: Vunakizumab Production Value Market Share Comparison (2021 & 2025 & 2032)
4.2 United States VS China: Vunakizumab Production Comparison
4.2.1 United States VS China: Vunakizumab Production Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: Vunakizumab Production Market Share Comparison (2021 & 2025 & 2032)
4.3 United States VS China: Vunakizumab Consumption Comparison
4.3.1 United States VS China: Vunakizumab Consumption Comparison (2021 & 2025 & 2032)
4.3.2 United States VS China: Vunakizumab Consumption Market Share Comparison (2021 & 2025 & 2032)
4.4 United States Based Vunakizumab Manufacturers and Market Share, 2021-2026
4.4.1 United States Based Vunakizumab Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Vunakizumab Production Value (2021-2026)
4.4.3 United States Based Manufacturers Vunakizumab Production (2021-2026)
4.5 China Based Vunakizumab Manufacturers and Market Share
4.5.1 China Based Vunakizumab Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Vunakizumab Production Value (2021-2026)
4.5.3 China Based Manufacturers Vunakizumab Production (2021-2026)
4.6 Rest of World Based Vunakizumab Manufacturers and Market Share, 2021-2026
4.6.1 Rest of World Based Vunakizumab Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Vunakizumab Production Value (2021-2026)
4.6.3 Rest of World Based Manufacturers Vunakizumab Production (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World Vunakizumab Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 120 mg / 1 ml
5.2.2 240 mg / 2 ml
5.3 Market Segment by Type
5.3.1 World Vunakizumab Production by Type (2021-2032)
5.3.2 World Vunakizumab Production Value by Type (2021-2032)
5.3.3 World Vunakizumab Average Price by Type (2021-2032)
6 MARKET ANALYSIS BY PRODUCTION TECHNOLOGY
6.1 World Vunakizumab Market Size Overview by Production Technology: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Production Technology
6.2.1 Innovator
6.2.2 Generic
6.3 Market Segment by Production Technology
6.3.1 World Vunakizumab Production by Production Technology (2021-2032)
6.3.2 World Vunakizumab Production Value by Production Technology (2021-2032)
6.3.3 World Vunakizumab Average Price by Production Technology (2021-2032)
7 MARKET ANALYSIS BY ANTIBODY TYPE
7.1 World Vunakizumab Market Size Overview by Antibody Type: 2021 VS 2025 VS 2032
7.2 Segment Introduction by Antibody Type
7.2.1 Monoclonal Antibody
7.2.2 Polyclonal Antibody
7.3 Market Segment by Antibody Type
7.3.1 World Vunakizumab Production by Antibody Type (2021-2032)
7.3.2 World Vunakizumab Production Value by Antibody Type (2021-2032)
7.3.3 World Vunakizumab Average Price by Antibody Type (2021-2032)
8 MARKET ANALYSIS BY SALES CHANNELS
8.1 World Vunakizumab Market Size Overview by Sales Channels: 2021 VS 2025 VS 2032
8.2 Segment Introduction by Sales Channels
8.2.1 Hospital
8.2.2 Retail
8.2.3 Online
8.3 Market Segment by Sales Channels
8.3.1 World Vunakizumab Production by Sales Channels (2021-2032)
8.3.2 World Vunakizumab Production Value by Sales Channels (2021-2032)
8.3.3 World Vunakizumab Average Price by Sales Channels (2021-2032)
9 MARKET ANALYSIS BY APPLICATION
9.1 World Vunakizumab Market Size Overview by Application: 2021 VS 2025 VS 2032
9.2 Segment Introduction by Application
9.2.1 Moderate to Severe Plaque Psoriasis
9.2.2 Ankylosing Spondylitis
9.2.3 Others
9.3 Market Segment by Application
9.3.1 World Vunakizumab Production by Application (2021-2032)
9.3.2 World Vunakizumab Production Value by Application (2021-2032)
9.3.3 World Vunakizumab Average Price by Application (2021-2032)
10 COMPANY PROFILES
10.1 Suzhou Shengdiya Biopharmaceutical
10.1.1 Suzhou Shengdiya Biopharmaceutical Details
10.1.2 Suzhou Shengdiya Biopharmaceutical Major Business
10.1.3 Suzhou Shengdiya Biopharmaceutical Vunakizumab Product and Services
10.1.4 Suzhou Shengdiya Biopharmaceutical Vunakizumab Production, Price, Value, Gross Margin and Market Share (2021-2026)
10.1.5 Suzhou Shengdiya Biopharmaceutical Recent Developments/Updates
10.1.6 Suzhou Shengdiya Biopharmaceutical Competitive Strengths & Weaknesses
10.2 Jiangsu Hengrui Medicine
10.2.1 Jiangsu Hengrui Medicine Details
10.2.2 Jiangsu Hengrui Medicine Major Business
10.2.3 Jiangsu Hengrui Medicine Vunakizumab Product and Services
10.2.4 Jiangsu Hengrui Medicine Vunakizumab Production, Price, Value, Gross Margin and Market Share (2021-2026)
10.2.5 Jiangsu Hengrui Medicine Recent Developments/Updates
10.2.6 Jiangsu Hengrui Medicine Competitive Strengths & Weaknesses
11 INDUSTRY CHAIN ANALYSIS
11.1 Vunakizumab Industry Chain
11.2 Vunakizumab Upstream Analysis
11.2.1 Vunakizumab Core Raw Materials
11.2.2 Main Manufacturers of Vunakizumab Core Raw Materials
11.3 Midstream Analysis
11.4 Downstream Analysis
11.5 Vunakizumab Production Mode
11.6 Vunakizumab Procurement Model
11.7 Vunakizumab Industry Sales Model and Sales Channels
11.7.1 Vunakizumab Sales Model
11.7.2 Vunakizumab Typical Distributors
12 RESEARCH FINDINGS AND CONCLUSION
13 APPENDIX
13.1 Methodology
13.2 Research Process and Data Source
13.3 Disclaimer
1.1 Vunakizumab Introduction
1.2 World Vunakizumab Supply & Forecast
1.2.1 World Vunakizumab Production Value (2021 & 2025 & 2032)
1.2.2 World Vunakizumab Production (2021-2032)
1.2.3 World Vunakizumab Pricing Trends (2021-2032)
1.3 World Vunakizumab Production by Region (Based on Production Site)
1.3.1 World Vunakizumab Production Value by Region (2021-2032)
1.3.2 World Vunakizumab Production by Region (2021-2032)
1.3.3 World Vunakizumab Average Price by Region (2021-2032)
1.3.4 North America Vunakizumab Production (2021-2032)
1.3.5 Europe Vunakizumab Production (2021-2032)
1.3.6 China Vunakizumab Production (2021-2032)
1.3.7 Japan Vunakizumab Production (2021-2032)
1.3.8 India Vunakizumab Production (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 Vunakizumab Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Vunakizumab Major Market Trends
2 DEMAND SUMMARY
2.1 World Vunakizumab Demand (2021-2032)
2.2 World Vunakizumab Consumption by Region
2.2.1 World Vunakizumab Consumption by Region (2021-2026)
2.2.2 World Vunakizumab Consumption Forecast by Region (2027-2032)
2.3 United States Vunakizumab Consumption (2021-2032)
2.4 China Vunakizumab Consumption (2021-2032)
2.5 Europe Vunakizumab Consumption (2021-2032)
2.6 Japan Vunakizumab Consumption (2021-2032)
2.7 South Korea Vunakizumab Consumption (2021-2032)
2.8 ASEAN Vunakizumab Consumption (2021-2032)
2.9 India Vunakizumab Consumption (2021-2032)
3 WORLD MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Vunakizumab Production Value by Manufacturer (2021-2026)
3.2 World Vunakizumab Production by Manufacturer (2021-2026)
3.3 World Vunakizumab Average Price by Manufacturer (2021-2026)
3.4 Vunakizumab Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Vunakizumab Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Vunakizumab in 2025
3.5.3 Global Concentration Ratios (CR8) for Vunakizumab in 2025
3.6 Vunakizumab Market: Overall Company Footprint Analysis
3.6.1 Vunakizumab Market: Region Footprint
3.6.2 Vunakizumab Market: Company Product Type Footprint
3.6.3 Vunakizumab Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Vunakizumab Production Value Comparison
4.1.1 United States VS China: Vunakizumab Production Value Comparison (2021 & 2025 & 2032)
4.1.2 United States VS China: Vunakizumab Production Value Market Share Comparison (2021 & 2025 & 2032)
4.2 United States VS China: Vunakizumab Production Comparison
4.2.1 United States VS China: Vunakizumab Production Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: Vunakizumab Production Market Share Comparison (2021 & 2025 & 2032)
4.3 United States VS China: Vunakizumab Consumption Comparison
4.3.1 United States VS China: Vunakizumab Consumption Comparison (2021 & 2025 & 2032)
4.3.2 United States VS China: Vunakizumab Consumption Market Share Comparison (2021 & 2025 & 2032)
4.4 United States Based Vunakizumab Manufacturers and Market Share, 2021-2026
4.4.1 United States Based Vunakizumab Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Vunakizumab Production Value (2021-2026)
4.4.3 United States Based Manufacturers Vunakizumab Production (2021-2026)
4.5 China Based Vunakizumab Manufacturers and Market Share
4.5.1 China Based Vunakizumab Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Vunakizumab Production Value (2021-2026)
4.5.3 China Based Manufacturers Vunakizumab Production (2021-2026)
4.6 Rest of World Based Vunakizumab Manufacturers and Market Share, 2021-2026
4.6.1 Rest of World Based Vunakizumab Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Vunakizumab Production Value (2021-2026)
4.6.3 Rest of World Based Manufacturers Vunakizumab Production (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World Vunakizumab Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 120 mg / 1 ml
5.2.2 240 mg / 2 ml
5.3 Market Segment by Type
5.3.1 World Vunakizumab Production by Type (2021-2032)
5.3.2 World Vunakizumab Production Value by Type (2021-2032)
5.3.3 World Vunakizumab Average Price by Type (2021-2032)
6 MARKET ANALYSIS BY PRODUCTION TECHNOLOGY
6.1 World Vunakizumab Market Size Overview by Production Technology: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Production Technology
6.2.1 Innovator
6.2.2 Generic
6.3 Market Segment by Production Technology
6.3.1 World Vunakizumab Production by Production Technology (2021-2032)
6.3.2 World Vunakizumab Production Value by Production Technology (2021-2032)
6.3.3 World Vunakizumab Average Price by Production Technology (2021-2032)
7 MARKET ANALYSIS BY ANTIBODY TYPE
7.1 World Vunakizumab Market Size Overview by Antibody Type: 2021 VS 2025 VS 2032
7.2 Segment Introduction by Antibody Type
7.2.1 Monoclonal Antibody
7.2.2 Polyclonal Antibody
7.3 Market Segment by Antibody Type
7.3.1 World Vunakizumab Production by Antibody Type (2021-2032)
7.3.2 World Vunakizumab Production Value by Antibody Type (2021-2032)
7.3.3 World Vunakizumab Average Price by Antibody Type (2021-2032)
8 MARKET ANALYSIS BY SALES CHANNELS
8.1 World Vunakizumab Market Size Overview by Sales Channels: 2021 VS 2025 VS 2032
8.2 Segment Introduction by Sales Channels
8.2.1 Hospital
8.2.2 Retail
8.2.3 Online
8.3 Market Segment by Sales Channels
8.3.1 World Vunakizumab Production by Sales Channels (2021-2032)
8.3.2 World Vunakizumab Production Value by Sales Channels (2021-2032)
8.3.3 World Vunakizumab Average Price by Sales Channels (2021-2032)
9 MARKET ANALYSIS BY APPLICATION
9.1 World Vunakizumab Market Size Overview by Application: 2021 VS 2025 VS 2032
9.2 Segment Introduction by Application
9.2.1 Moderate to Severe Plaque Psoriasis
9.2.2 Ankylosing Spondylitis
9.2.3 Others
9.3 Market Segment by Application
9.3.1 World Vunakizumab Production by Application (2021-2032)
9.3.2 World Vunakizumab Production Value by Application (2021-2032)
9.3.3 World Vunakizumab Average Price by Application (2021-2032)
10 COMPANY PROFILES
10.1 Suzhou Shengdiya Biopharmaceutical
10.1.1 Suzhou Shengdiya Biopharmaceutical Details
10.1.2 Suzhou Shengdiya Biopharmaceutical Major Business
10.1.3 Suzhou Shengdiya Biopharmaceutical Vunakizumab Product and Services
10.1.4 Suzhou Shengdiya Biopharmaceutical Vunakizumab Production, Price, Value, Gross Margin and Market Share (2021-2026)
10.1.5 Suzhou Shengdiya Biopharmaceutical Recent Developments/Updates
10.1.6 Suzhou Shengdiya Biopharmaceutical Competitive Strengths & Weaknesses
10.2 Jiangsu Hengrui Medicine
10.2.1 Jiangsu Hengrui Medicine Details
10.2.2 Jiangsu Hengrui Medicine Major Business
10.2.3 Jiangsu Hengrui Medicine Vunakizumab Product and Services
10.2.4 Jiangsu Hengrui Medicine Vunakizumab Production, Price, Value, Gross Margin and Market Share (2021-2026)
10.2.5 Jiangsu Hengrui Medicine Recent Developments/Updates
10.2.6 Jiangsu Hengrui Medicine Competitive Strengths & Weaknesses
11 INDUSTRY CHAIN ANALYSIS
11.1 Vunakizumab Industry Chain
11.2 Vunakizumab Upstream Analysis
11.2.1 Vunakizumab Core Raw Materials
11.2.2 Main Manufacturers of Vunakizumab Core Raw Materials
11.3 Midstream Analysis
11.4 Downstream Analysis
11.5 Vunakizumab Production Mode
11.6 Vunakizumab Procurement Model
11.7 Vunakizumab Industry Sales Model and Sales Channels
11.7.1 Vunakizumab Sales Model
11.7.2 Vunakizumab Typical Distributors
12 RESEARCH FINDINGS AND CONCLUSION
13 APPENDIX
13.1 Methodology
13.2 Research Process and Data Source
13.3 Disclaimer
LIST OF TABLES
Table 1. World Vunakizumab Production Value by Region (2021, 2025 and 2032) & (USD Million)
Table 2. World Vunakizumab Production Value by Region (2021-2026) & (USD Million)
Table 3. World Vunakizumab Production Value by Region (2027-2032) & (USD Million)
Table 4. World Vunakizumab Production Value Market Share by Region (2021-2026)
Table 5. World Vunakizumab Production Value Market Share by Region (2027-2032)
Table 6. World Vunakizumab Production by Region (2021-2026) & (Units)
Table 7. World Vunakizumab Production by Region (2027-2032) & (Units)
Table 8. World Vunakizumab Production Market Share by Region (2021-2026)
Table 9. World Vunakizumab Production Market Share by Region (2027-2032)
Table 10. World Vunakizumab Average Price by Region (2021-2026) & (US$/Unit)
Table 11. World Vunakizumab Average Price by Region (2027-2032) & (US$/Unit)
Table 12. Vunakizumab Major Market Trends
Table 13. World Vunakizumab Consumption Growth Rate Forecast by Region (2021 & 2025 & 2032) & (Units)
Table 14. World Vunakizumab Consumption by Region (2021-2026) & (Units)
Table 15. World Vunakizumab Consumption Forecast by Region (2027-2032) & (Units)
Table 16. World Vunakizumab Production Value by Manufacturer (2021-2026) & (USD Million)
Table 17. Production Value Market Share of Key Vunakizumab Producers in 2025
Table 18. World Vunakizumab Production by Manufacturer (2021-2026) & (Units)
Table 19. Production Market Share of Key Vunakizumab Producers in 2025
Table 20. World Vunakizumab Average Price by Manufacturer (2021-2026) & (US$/Unit)
Table 21. Global Vunakizumab Company Evaluation Quadrant
Table 22. World Vunakizumab Industry Rank of Major Manufacturers, Based on Production Value in 2025
Table 23. Head Office and Vunakizumab Production Site of Key Manufacturer
Table 24. Vunakizumab Market: Company Product Type Footprint
Table 25. Vunakizumab Market: Company Product Application Footprint
Table 26. Vunakizumab Competitive Factors
Table 27. Vunakizumab New Entrant and Capacity Expansion Plans
Table 28. Vunakizumab Mergers & Acquisitions Activity
Table 29. United States VS China Vunakizumab Production Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 30. United States VS China Vunakizumab Production Comparison, (2021 & 2025 & 2032) & (Units)
Table 31. United States VS China Vunakizumab Consumption Comparison, (2021 & 2025 & 2032) & (Units)
Table 32. United States Based Vunakizumab Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Vunakizumab Production Value, (2021-2026) & (USD Million)
Table 34. United States Based Manufacturers Vunakizumab Production Value Market Share (2021-2026)
Table 35. United States Based Manufacturers Vunakizumab Production (2021-2026) & (Units)
Table 36. United States Based Manufacturers Vunakizumab Production Market Share (2021-2026)
Table 37. China Based Vunakizumab Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Vunakizumab Production Value, (2021-2026) & (USD Million)
Table 39. China Based Manufacturers Vunakizumab Production Value Market Share (2021-2026)
Table 40. China Based Manufacturers Vunakizumab Production, (2021-2026) & (Units)
Table 41. China Based Manufacturers Vunakizumab Production Market Share (2021-2026)
Table 42. Rest of World Based Vunakizumab Manufacturers, Headquarters and Production Site (State, Country)
Table 43. Rest of World Based Manufacturers Vunakizumab Production Value, (2021-2026) & (USD Million)
Table 44. Rest of World Based Manufacturers Vunakizumab Production Value Market Share (2021-2026)
Table 45. Rest of World Based Manufacturers Vunakizumab Production, (2021-2026) & (Units)
Table 46. Rest of World Based Manufacturers Vunakizumab Production Market Share (2021-2026)
Table 47. World Vunakizumab Production Value by Type, (USD Million), 2021 & 2025 & 2032
Table 48. World Vunakizumab Production by Type (2021-2026) & (Units)
Table 49. World Vunakizumab Production by Type (2027-2032) & (Units)
Table 50. World Vunakizumab Production Value by Type (2021-2026) & (USD Million)
Table 51. World Vunakizumab Production Value by Type (2027-2032) & (USD Million)
Table 52. World Vunakizumab Average Price by Type (2021-2026) & (US$/Unit)
Table 53. World Vunakizumab Average Price by Type (2027-2032) & (US$/Unit)
Table 54. World Vunakizumab Production Value by Production Technology, (USD Million), 2021 & 2025 & 2032
Table 55. World Vunakizumab Production by Production Technology (2021-2026) & (Units)
Table 56. World Vunakizumab Production by Production Technology (2027-2032) & (Units)
Table 57. World Vunakizumab Production Value by Production Technology (2021-2026) & (USD Million)
Table 58. World Vunakizumab Production Value by Production Technology (2027-2032) & (USD Million)
Table 59. World Vunakizumab Average Price by Production Technology (2021-2026) & (US$/Unit)
Table 60. World Vunakizumab Average Price by Production Technology (2027-2032) & (US$/Unit)
Table 61. World Vunakizumab Production Value by Antibody Type, (USD Million), 2021 & 2025 & 2032
Table 62. World Vunakizumab Production by Antibody Type (2021-2026) & (Units)
Table 63. World Vunakizumab Production by Antibody Type (2027-2032) & (Units)
Table 64. World Vunakizumab Production Value by Antibody Type (2021-2026) & (USD Million)
Table 65. World Vunakizumab Production Value by Antibody Type (2027-2032) & (USD Million)
Table 66. World Vunakizumab Average Price by Antibody Type (2021-2026) & (US$/Unit)
Table 67. World Vunakizumab Average Price by Antibody Type (2027-2032) & (US$/Unit)
Table 68. World Vunakizumab Production Value by Sales Channels, (USD Million), 2021 & 2025 & 2032
Table 69. World Vunakizumab Production by Sales Channels (2021-2026) & (Units)
Table 70. World Vunakizumab Production by Sales Channels (2027-2032) & (Units)
Table 71. World Vunakizumab Production Value by Sales Channels (2021-2026) & (USD Million)
Table 72. World Vunakizumab Production Value by Sales Channels (2027-2032) & (USD Million)
Table 73. World Vunakizumab Average Price by Sales Channels (2021-2026) & (US$/Unit)
Table 74. World Vunakizumab Average Price by Sales Channels (2027-2032) & (US$/Unit)
Table 75. World Vunakizumab Production Value by Application, (USD Million), 2021 & 2025 & 2032
Table 76. World Vunakizumab Production by Application (2021-2026) & (Units)
Table 77. World Vunakizumab Production by Application (2027-2032) & (Units)
Table 78. World Vunakizumab Production Value by Application (2021-2026) & (USD Million)
Table 79. World Vunakizumab Production Value by Application (2027-2032) & (USD Million)
Table 80. World Vunakizumab Average Price by Application (2021-2026) & (US$/Unit)
Table 81. World Vunakizumab Average Price by Application (2027-2032) & (US$/Unit)
Table 82. Suzhou Shengdiya Biopharmaceutical Basic Information, Manufacturing Base and Competitors
Table 83. Suzhou Shengdiya Biopharmaceutical Major Business
Table 84. Suzhou Shengdiya Biopharmaceutical Vunakizumab Product and Services
Table 85. Suzhou Shengdiya Biopharmaceutical Vunakizumab Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 86. Suzhou Shengdiya Biopharmaceutical Recent Developments/Updates
Table 87. Suzhou Shengdiya Biopharmaceutical Competitive Strengths & Weaknesses
Table 88. Jiangsu Hengrui Medicine Basic Information, Manufacturing Base and Competitors
Table 89. Jiangsu Hengrui Medicine Major Business
Table 90. Jiangsu Hengrui Medicine Vunakizumab Product and Services
Table 91. Jiangsu Hengrui Medicine Vunakizumab Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 92. Jiangsu Hengrui Medicine Recent Developments/Updates
Table 93. Jiangsu Hengrui Medicine Competitive Strengths & Weaknesses
Table 94. Global Key Players of Vunakizumab Upstream (Raw Materials)
Table 95. Global Vunakizumab Typical Customers
Table 96. Vunakizumab Typical Distributors
Table 1. World Vunakizumab Production Value by Region (2021, 2025 and 2032) & (USD Million)
Table 2. World Vunakizumab Production Value by Region (2021-2026) & (USD Million)
Table 3. World Vunakizumab Production Value by Region (2027-2032) & (USD Million)
Table 4. World Vunakizumab Production Value Market Share by Region (2021-2026)
Table 5. World Vunakizumab Production Value Market Share by Region (2027-2032)
Table 6. World Vunakizumab Production by Region (2021-2026) & (Units)
Table 7. World Vunakizumab Production by Region (2027-2032) & (Units)
Table 8. World Vunakizumab Production Market Share by Region (2021-2026)
Table 9. World Vunakizumab Production Market Share by Region (2027-2032)
Table 10. World Vunakizumab Average Price by Region (2021-2026) & (US$/Unit)
Table 11. World Vunakizumab Average Price by Region (2027-2032) & (US$/Unit)
Table 12. Vunakizumab Major Market Trends
Table 13. World Vunakizumab Consumption Growth Rate Forecast by Region (2021 & 2025 & 2032) & (Units)
Table 14. World Vunakizumab Consumption by Region (2021-2026) & (Units)
Table 15. World Vunakizumab Consumption Forecast by Region (2027-2032) & (Units)
Table 16. World Vunakizumab Production Value by Manufacturer (2021-2026) & (USD Million)
Table 17. Production Value Market Share of Key Vunakizumab Producers in 2025
Table 18. World Vunakizumab Production by Manufacturer (2021-2026) & (Units)
Table 19. Production Market Share of Key Vunakizumab Producers in 2025
Table 20. World Vunakizumab Average Price by Manufacturer (2021-2026) & (US$/Unit)
Table 21. Global Vunakizumab Company Evaluation Quadrant
Table 22. World Vunakizumab Industry Rank of Major Manufacturers, Based on Production Value in 2025
Table 23. Head Office and Vunakizumab Production Site of Key Manufacturer
Table 24. Vunakizumab Market: Company Product Type Footprint
Table 25. Vunakizumab Market: Company Product Application Footprint
Table 26. Vunakizumab Competitive Factors
Table 27. Vunakizumab New Entrant and Capacity Expansion Plans
Table 28. Vunakizumab Mergers & Acquisitions Activity
Table 29. United States VS China Vunakizumab Production Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 30. United States VS China Vunakizumab Production Comparison, (2021 & 2025 & 2032) & (Units)
Table 31. United States VS China Vunakizumab Consumption Comparison, (2021 & 2025 & 2032) & (Units)
Table 32. United States Based Vunakizumab Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Vunakizumab Production Value, (2021-2026) & (USD Million)
Table 34. United States Based Manufacturers Vunakizumab Production Value Market Share (2021-2026)
Table 35. United States Based Manufacturers Vunakizumab Production (2021-2026) & (Units)
Table 36. United States Based Manufacturers Vunakizumab Production Market Share (2021-2026)
Table 37. China Based Vunakizumab Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Vunakizumab Production Value, (2021-2026) & (USD Million)
Table 39. China Based Manufacturers Vunakizumab Production Value Market Share (2021-2026)
Table 40. China Based Manufacturers Vunakizumab Production, (2021-2026) & (Units)
Table 41. China Based Manufacturers Vunakizumab Production Market Share (2021-2026)
Table 42. Rest of World Based Vunakizumab Manufacturers, Headquarters and Production Site (State, Country)
Table 43. Rest of World Based Manufacturers Vunakizumab Production Value, (2021-2026) & (USD Million)
Table 44. Rest of World Based Manufacturers Vunakizumab Production Value Market Share (2021-2026)
Table 45. Rest of World Based Manufacturers Vunakizumab Production, (2021-2026) & (Units)
Table 46. Rest of World Based Manufacturers Vunakizumab Production Market Share (2021-2026)
Table 47. World Vunakizumab Production Value by Type, (USD Million), 2021 & 2025 & 2032
Table 48. World Vunakizumab Production by Type (2021-2026) & (Units)
Table 49. World Vunakizumab Production by Type (2027-2032) & (Units)
Table 50. World Vunakizumab Production Value by Type (2021-2026) & (USD Million)
Table 51. World Vunakizumab Production Value by Type (2027-2032) & (USD Million)
Table 52. World Vunakizumab Average Price by Type (2021-2026) & (US$/Unit)
Table 53. World Vunakizumab Average Price by Type (2027-2032) & (US$/Unit)
Table 54. World Vunakizumab Production Value by Production Technology, (USD Million), 2021 & 2025 & 2032
Table 55. World Vunakizumab Production by Production Technology (2021-2026) & (Units)
Table 56. World Vunakizumab Production by Production Technology (2027-2032) & (Units)
Table 57. World Vunakizumab Production Value by Production Technology (2021-2026) & (USD Million)
Table 58. World Vunakizumab Production Value by Production Technology (2027-2032) & (USD Million)
Table 59. World Vunakizumab Average Price by Production Technology (2021-2026) & (US$/Unit)
Table 60. World Vunakizumab Average Price by Production Technology (2027-2032) & (US$/Unit)
Table 61. World Vunakizumab Production Value by Antibody Type, (USD Million), 2021 & 2025 & 2032
Table 62. World Vunakizumab Production by Antibody Type (2021-2026) & (Units)
Table 63. World Vunakizumab Production by Antibody Type (2027-2032) & (Units)
Table 64. World Vunakizumab Production Value by Antibody Type (2021-2026) & (USD Million)
Table 65. World Vunakizumab Production Value by Antibody Type (2027-2032) & (USD Million)
Table 66. World Vunakizumab Average Price by Antibody Type (2021-2026) & (US$/Unit)
Table 67. World Vunakizumab Average Price by Antibody Type (2027-2032) & (US$/Unit)
Table 68. World Vunakizumab Production Value by Sales Channels, (USD Million), 2021 & 2025 & 2032
Table 69. World Vunakizumab Production by Sales Channels (2021-2026) & (Units)
Table 70. World Vunakizumab Production by Sales Channels (2027-2032) & (Units)
Table 71. World Vunakizumab Production Value by Sales Channels (2021-2026) & (USD Million)
Table 72. World Vunakizumab Production Value by Sales Channels (2027-2032) & (USD Million)
Table 73. World Vunakizumab Average Price by Sales Channels (2021-2026) & (US$/Unit)
Table 74. World Vunakizumab Average Price by Sales Channels (2027-2032) & (US$/Unit)
Table 75. World Vunakizumab Production Value by Application, (USD Million), 2021 & 2025 & 2032
Table 76. World Vunakizumab Production by Application (2021-2026) & (Units)
Table 77. World Vunakizumab Production by Application (2027-2032) & (Units)
Table 78. World Vunakizumab Production Value by Application (2021-2026) & (USD Million)
Table 79. World Vunakizumab Production Value by Application (2027-2032) & (USD Million)
Table 80. World Vunakizumab Average Price by Application (2021-2026) & (US$/Unit)
Table 81. World Vunakizumab Average Price by Application (2027-2032) & (US$/Unit)
Table 82. Suzhou Shengdiya Biopharmaceutical Basic Information, Manufacturing Base and Competitors
Table 83. Suzhou Shengdiya Biopharmaceutical Major Business
Table 84. Suzhou Shengdiya Biopharmaceutical Vunakizumab Product and Services
Table 85. Suzhou Shengdiya Biopharmaceutical Vunakizumab Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 86. Suzhou Shengdiya Biopharmaceutical Recent Developments/Updates
Table 87. Suzhou Shengdiya Biopharmaceutical Competitive Strengths & Weaknesses
Table 88. Jiangsu Hengrui Medicine Basic Information, Manufacturing Base and Competitors
Table 89. Jiangsu Hengrui Medicine Major Business
Table 90. Jiangsu Hengrui Medicine Vunakizumab Product and Services
Table 91. Jiangsu Hengrui Medicine Vunakizumab Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 92. Jiangsu Hengrui Medicine Recent Developments/Updates
Table 93. Jiangsu Hengrui Medicine Competitive Strengths & Weaknesses
Table 94. Global Key Players of Vunakizumab Upstream (Raw Materials)
Table 95. Global Vunakizumab Typical Customers
Table 96. Vunakizumab Typical Distributors
LIST OF FIGURES
Figure 1. Vunakizumab Picture
Figure 2. World Vunakizumab Production Value: 2021 & 2025 & 2032, (USD Million)
Figure 3. World Vunakizumab Production Value and Forecast (2021-2032) & (USD Million)
Figure 4. World Vunakizumab Production (2021-2032) & (Units)
Figure 5. World Vunakizumab Average Price (2021-2032) & (US$/Unit)
Figure 6. World Vunakizumab Production Value Market Share by Region (2021-2032)
Figure 7. World Vunakizumab Production Market Share by Region (2021-2032)
Figure 8. North America Vunakizumab Production (2021-2032) & (Units)
Figure 9. Europe Vunakizumab Production (2021-2032) & (Units)
Figure 10. China Vunakizumab Production (2021-2032) & (Units)
Figure 11. Japan Vunakizumab Production (2021-2032) & (Units)
Figure 12. India Vunakizumab Production (2021-2032) & (Units)
Figure 13. Vunakizumab Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Vunakizumab Consumption (2021-2032) & (Units)
Figure 16. World Vunakizumab Consumption Market Share by Region (2021-2032)
Figure 17. United States Vunakizumab Consumption (2021-2032) & (Units)
Figure 18. China Vunakizumab Consumption (2021-2032) & (Units)
Figure 19. Europe Vunakizumab Consumption (2021-2032) & (Units)
Figure 20. Japan Vunakizumab Consumption (2021-2032) & (Units)
Figure 21. South Korea Vunakizumab Consumption (2021-2032) & (Units)
Figure 22. ASEAN Vunakizumab Consumption (2021-2032) & (Units)
Figure 23. India Vunakizumab Consumption (2021-2032) & (Units)
Figure 24. Producer Shipments of Vunakizumab by Manufacturer Revenue ($MM) and Market Share (%): 2025
Figure 25. Global Four-firm Concentration Ratios (CR4) for Vunakizumab Markets in 2025
Figure 26. Global Four-firm Concentration Ratios (CR8) for Vunakizumab Markets in 2025
Figure 27. United States VS China: Vunakizumab Production Value Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: Vunakizumab Production Market Share Comparison (2021 & 2025 & 2032)
Figure 29. United States VS China: Vunakizumab Consumption Market Share Comparison (2021 & 2025 & 2032)
Figure 30. United States Based Manufacturers Vunakizumab Production Market Share 2025
Figure 31. China Based Manufacturers Vunakizumab Production Market Share 2025
Figure 32. Rest of World Based Manufacturers Vunakizumab Production Market Share 2025
Figure 33. World Vunakizumab Production Value by Type, (USD Million), 2021 & 2025 & 2032
Figure 34. World Vunakizumab Production Value Market Share by Type in 2025
Figure 35. 120 mg / 1 ml
Figure 36. 240 mg / 2 ml
Figure 37. World Vunakizumab Production Market Share by Type (2021-2032)
Figure 38. World Vunakizumab Production Value Market Share by Type (2021-2032)
Figure 39. World Vunakizumab Average Price by Type (2021-2032) & (US$/Unit)
Figure 40. World Vunakizumab Production Value by Production Technology, (USD Million), 2021 & 2025 & 2032
Figure 41. World Vunakizumab Production Value Market Share by Production Technology in 2025
Figure 42. Innovator
Figure 43. Generic
Figure 44. World Vunakizumab Production Market Share by Production Technology (2021-2032)
Figure 45. World Vunakizumab Production Value Market Share by Production Technology (2021-2032)
Figure 46. World Vunakizumab Average Price by Production Technology (2021-2032) & (US$/Unit)
Figure 47. World Vunakizumab Production Value by Antibody Type, (USD Million), 2021 & 2025 & 2032
Figure 48. World Vunakizumab Production Value Market Share by Antibody Type in 2025
Figure 49. Monoclonal Antibody
Figure 50. Polyclonal Antibody
Figure 51. World Vunakizumab Production Market Share by Antibody Type (2021-2032)
Figure 52. World Vunakizumab Production Value Market Share by Antibody Type (2021-2032)
Figure 53. World Vunakizumab Average Price by Antibody Type (2021-2032) & (US$/Unit)
Figure 54. World Vunakizumab Production Value by Sales Channels, (USD Million), 2021 & 2025 & 2032
Figure 55. World Vunakizumab Production Value Market Share by Sales Channels in 2025
Figure 56. Hospital
Figure 57. Retail
Figure 58. Online
Figure 59. World Vunakizumab Production Market Share by Sales Channels (2021-2032)
Figure 60. World Vunakizumab Production Value Market Share by Sales Channels (2021-2032)
Figure 61. World Vunakizumab Average Price by Sales Channels (2021-2032) & (US$/Unit)
Figure 62. World Vunakizumab Production Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 63. World Vunakizumab Production Value Market Share by Application in 2025
Figure 64. Moderate to Severe Plaque Psoriasis
Figure 65. Ankylosing Spondylitis
Figure 66. Others
Figure 67. World Vunakizumab Production Market Share by Application (2021-2032)
Figure 68. World Vunakizumab Production Value Market Share by Application (2021-2032)
Figure 69. World Vunakizumab Average Price by Application (2021-2032) & (US$/Unit)
Figure 70. Vunakizumab Industry Chain
Figure 71. Vunakizumab Procurement Model
Figure 72. Vunakizumab Sales Model
Figure 73. Vunakizumab Sales Channels, Direct Sales, and Distribution
Figure 74. Methodology
Figure 75. Research Process and Data Source
Figure 1. Vunakizumab Picture
Figure 2. World Vunakizumab Production Value: 2021 & 2025 & 2032, (USD Million)
Figure 3. World Vunakizumab Production Value and Forecast (2021-2032) & (USD Million)
Figure 4. World Vunakizumab Production (2021-2032) & (Units)
Figure 5. World Vunakizumab Average Price (2021-2032) & (US$/Unit)
Figure 6. World Vunakizumab Production Value Market Share by Region (2021-2032)
Figure 7. World Vunakizumab Production Market Share by Region (2021-2032)
Figure 8. North America Vunakizumab Production (2021-2032) & (Units)
Figure 9. Europe Vunakizumab Production (2021-2032) & (Units)
Figure 10. China Vunakizumab Production (2021-2032) & (Units)
Figure 11. Japan Vunakizumab Production (2021-2032) & (Units)
Figure 12. India Vunakizumab Production (2021-2032) & (Units)
Figure 13. Vunakizumab Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Vunakizumab Consumption (2021-2032) & (Units)
Figure 16. World Vunakizumab Consumption Market Share by Region (2021-2032)
Figure 17. United States Vunakizumab Consumption (2021-2032) & (Units)
Figure 18. China Vunakizumab Consumption (2021-2032) & (Units)
Figure 19. Europe Vunakizumab Consumption (2021-2032) & (Units)
Figure 20. Japan Vunakizumab Consumption (2021-2032) & (Units)
Figure 21. South Korea Vunakizumab Consumption (2021-2032) & (Units)
Figure 22. ASEAN Vunakizumab Consumption (2021-2032) & (Units)
Figure 23. India Vunakizumab Consumption (2021-2032) & (Units)
Figure 24. Producer Shipments of Vunakizumab by Manufacturer Revenue ($MM) and Market Share (%): 2025
Figure 25. Global Four-firm Concentration Ratios (CR4) for Vunakizumab Markets in 2025
Figure 26. Global Four-firm Concentration Ratios (CR8) for Vunakizumab Markets in 2025
Figure 27. United States VS China: Vunakizumab Production Value Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: Vunakizumab Production Market Share Comparison (2021 & 2025 & 2032)
Figure 29. United States VS China: Vunakizumab Consumption Market Share Comparison (2021 & 2025 & 2032)
Figure 30. United States Based Manufacturers Vunakizumab Production Market Share 2025
Figure 31. China Based Manufacturers Vunakizumab Production Market Share 2025
Figure 32. Rest of World Based Manufacturers Vunakizumab Production Market Share 2025
Figure 33. World Vunakizumab Production Value by Type, (USD Million), 2021 & 2025 & 2032
Figure 34. World Vunakizumab Production Value Market Share by Type in 2025
Figure 35. 120 mg / 1 ml
Figure 36. 240 mg / 2 ml
Figure 37. World Vunakizumab Production Market Share by Type (2021-2032)
Figure 38. World Vunakizumab Production Value Market Share by Type (2021-2032)
Figure 39. World Vunakizumab Average Price by Type (2021-2032) & (US$/Unit)
Figure 40. World Vunakizumab Production Value by Production Technology, (USD Million), 2021 & 2025 & 2032
Figure 41. World Vunakizumab Production Value Market Share by Production Technology in 2025
Figure 42. Innovator
Figure 43. Generic
Figure 44. World Vunakizumab Production Market Share by Production Technology (2021-2032)
Figure 45. World Vunakizumab Production Value Market Share by Production Technology (2021-2032)
Figure 46. World Vunakizumab Average Price by Production Technology (2021-2032) & (US$/Unit)
Figure 47. World Vunakizumab Production Value by Antibody Type, (USD Million), 2021 & 2025 & 2032
Figure 48. World Vunakizumab Production Value Market Share by Antibody Type in 2025
Figure 49. Monoclonal Antibody
Figure 50. Polyclonal Antibody
Figure 51. World Vunakizumab Production Market Share by Antibody Type (2021-2032)
Figure 52. World Vunakizumab Production Value Market Share by Antibody Type (2021-2032)
Figure 53. World Vunakizumab Average Price by Antibody Type (2021-2032) & (US$/Unit)
Figure 54. World Vunakizumab Production Value by Sales Channels, (USD Million), 2021 & 2025 & 2032
Figure 55. World Vunakizumab Production Value Market Share by Sales Channels in 2025
Figure 56. Hospital
Figure 57. Retail
Figure 58. Online
Figure 59. World Vunakizumab Production Market Share by Sales Channels (2021-2032)
Figure 60. World Vunakizumab Production Value Market Share by Sales Channels (2021-2032)
Figure 61. World Vunakizumab Average Price by Sales Channels (2021-2032) & (US$/Unit)
Figure 62. World Vunakizumab Production Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 63. World Vunakizumab Production Value Market Share by Application in 2025
Figure 64. Moderate to Severe Plaque Psoriasis
Figure 65. Ankylosing Spondylitis
Figure 66. Others
Figure 67. World Vunakizumab Production Market Share by Application (2021-2032)
Figure 68. World Vunakizumab Production Value Market Share by Application (2021-2032)
Figure 69. World Vunakizumab Average Price by Application (2021-2032) & (US$/Unit)
Figure 70. Vunakizumab Industry Chain
Figure 71. Vunakizumab Procurement Model
Figure 72. Vunakizumab Sales Model
Figure 73. Vunakizumab Sales Channels, Direct Sales, and Distribution
Figure 74. Methodology
Figure 75. Research Process and Data Source
